NGM Clinical Study Site 109 is a clinical research site located in Indianapolis, Indiana, United States.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
NGM Clinical Study Site 109 has participated in 1 clinical trials.
Therapeutic areas: Primary Sclerosing Cholangitis.
Sponsors: NGM Biopharmaceuticals, Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Indiana · View every site in Indianapolis
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NGM Clinical Study Site 109 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NGM Clinical Study Site 109 has 1 clinical trials on record. Their work covers Primary Sclerosing Cholangitis.
NGM Clinical Study Site 109 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.